The shareholders of Frisq Holding AB (publ), reg. no. 556959-2867, (the "Company"), are hereby convened to the annual general meeting to be held on Friday 26 February 2021, at 14.00 at Baker & McKenzie's premises at Vasagatan 7 in Stockholm. Information with respect to the coronavirusDue to the development of the coronavirus the goal is …
More-
Notice of annual general meeting in Frisq Holding AB (publ)
-
Bokslutskommuniké 2020
Januari-december 2020 VD-kommentar För oss som jobbar i vårdsektorn var det fjärde kvartalet 2020 lika präglat av den globala pandemin som tidigare kvartal, nästan ännu mer eftersom vi tyvärr drabbats av en andra coronavåg innan vi hunnit börja vaccinera. Det är ett bekymmersamt läge för världens regeringar och vad som kallas ”utmaning” för dess vårdsektorer …
More -
Report Q4 and Full Year 2020
January-December 2020 CEO Statement For us who work in the healthcare sector, the fourth quarter of 2020 was characterized as much by the global pandemic as previous quarters; In fact, almost more so since we have unfortunately been hit by a second corona wave before commencing large-scale vaccinations. It is a worrying situation for the …
More -
Månadsbrev december 2020
Bäste aktieägare i FRISQ, I takt med att vi närmar oss 2021 ser många fram emot att sätta punkt för 2020. Vår planet drabbades av den värsta pandemin på 100 år, vilken medförde otaliga tragedier och mängder sjuka och avlidna människor. De flesta av av oss känner någon som blivit sjuk och kanske t o …
More -
Monthly newsletter December 2020
Dear FRISQ Shareholder, As we are closing in on a new year, most of us cannot wait to have 2020 over and done with. The planet was hit by its worst pandemic in 100 years which led to innumerable tragedies with scores of people unwell, seriously ill or even worse. Many of us know someone who …
More -
Monthly newsletter: November 2020
The month of November brought with it several positive changes. FRISQ expanded its cooperation with Capio, signing an agreement with Capio Orthopedic, and started investing in the UK to meet the demands of this very significant market. FRISQ is seeing an emerging interest from both private and public health services in the United Kingdom. Local …
More